RNA Outsourcing Solutions

  1. Services For Advancing mRNA-LNPs From Bench To Clinic 2/27/2023

    Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

  2. Innovative Formulations And Higher Drug Loads Across The Life-Cycle 11/20/2025

    Advanced particle engineering enhances the performance and life-cycle of therapeutics. Superior bioavailability, higher drug load, and improved stability are enabled for small and large molecules.

  3. Our Spokane Foreign Trade Zone (FTZ) 12/10/2025

    Foreign Trade Zones help businesses cut costs and improve efficiency by deferring or eliminating tariffs, streamlining imports, and enabling faster market access while maintaining flexibility for global distribution.

  4. mRNA-LNP CDMO Services 4/26/2024

    Browse this brochure full of information on manufacturing grades, services, validation, and more that Vernal Biosciences can support.

  5. GMP mRNA And LNP-mRNA Manufacturing 5/13/2024

    Easily scale your GMP mRNA projects

  6. RNA Therapies 5/15/2024

    One Team, One Roof, One CDMO

    Recipharm Advanced Bio's expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.

  7. Enabling Capabilities And Solutions For All mRNA (Nucleic Acid) Platforms 6/6/2022

    Trust an experienced and trustworthy partner who understands the varying challenges you face and helps you solve them efficiently, safely and speedily.

  8. Comprehensive mRNA Solutions 1/31/2025

    Curia’s combined expertise and a proven track record of success in key scientific disciplines including molecular biology, protein production and analysis, enzymes, nucleosides and lipids is the foundation of our mRNA solution. Partner with us and harness our ability to provide high-quality constructs through in-house research and analysis capabilities that enable accelerated timelines for delivery.

  9. Non-Viral Gene Delivery (NVGD) Using Polymeric-Nano Particles

    Examine a NVGD platform that tackles the primary obstacle hindering gene editing therapies: efficient delivery. Utilizing engineered nanoparticles, the platform overcomes limitations associated with payload size.

  10. Accelerate Development With Large-Scale mRNA And LNP Production 10/16/2024

    Achieve scalable purity with Vernal Biosciences' mRNA and lipid nanoparticle (LNP) large-scale production, tailored to meet the demands of your preclinical studies, including dose range finding and toxicology assessments.